Ask the Experts: Optimizing Cotreatment of HCV and HIV Infection

Listen as expert faculty answer clinicians’ questions about specific challenges in managing HCV/HIV coinfection, including how to apply guideline-based strategies, avoid common DAA and ART interactions, incorporate recent therapy approvals, and more.
Susanna Naggie, MD, MHS
Format: Audio (.mp3)
File Size: 3.7 MB
Released: September 13, 2018

Acknowledgements

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an independent educational grant from
Gilead Sciences

Related Content

Slide from CCO on the importance of vaccinating older adults against shingles, with examples of how to overcome common clinical challenges.

Susan Schrimpf Davis, DO Cynthia J. Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD Deborah A. Milito, PharmD, BCGP, FASCP Released: July 31, 2020

Expert commentary on prevention and emerging treatment strategies for the COVID-19 pandemic from CCO

Daniel R. Kuritzkes, MD Released: March 19, 2020

Celine Gounder, MD, ScM, FIDSA: how healthcare providers can be prepared for when coronavirus comes to them. Testing for COVID-19, symptoms, screening, from CCO

Celine Gounder, MD, ScM, FIDSA Released: March 13, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue